Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve consider and approve the Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd has informed BSE that a Board Meeting is scheduled for 28 May 2026 at 2:00 PM at their registered office in Indore. The meeting will consider and approve the Audited Financial Statements for the year ended 31 March 2026, including Balance Sheet, Statement of Profit and Loss, Cash Flow and Notes. The Board will also take on record the Auditors Report and consider related party transactions. This is a routine board meeting notice for annual financial results approval. No specific financial numbers or preliminary results are provided in this filing.
This is a standard notice announcing an upcoming board meeting to approve annual results. The actual financial results and any material developments will only be disclosed after the meeting. Shareholders should await the official results announcement expected after 28 May 2026.